Pregabalin Completed Phase 3 Trials for Idiopathic Restless Legs Syndrome Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00806026Long Term Study Of Pregabalin In Idiopathic Restless Legs Syndrome Patients